BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 14585411)

  • 21. Liver transplantation for hilar cholangiocarcinoma.
    Thelen A; Neuhaus P
    J Hepatobiliary Pancreat Surg; 2007; 14(5):469-75. PubMed ID: 17909715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholangiocarcinoma complicating recurrent primary sclerosing cholangitis after liver transplantation.
    Khorsandi SE; Salvans S; Zen Y; Agarwal K; Jassem W; Heaton N
    Transpl Int; 2011 Oct; 24(10):e93-6. PubMed ID: 21884553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radical operation after portal embolization for tumor of hilar bile duct.
    Kawasaki S; Makuuchi M; Miyagawa S; Kakazu T
    J Am Coll Surg; 1994 May; 178(5):480-6. PubMed ID: 7909486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results.
    Friman S; Foss A; Isoniemi H; Olausson M; Höckerstedt K; Yamamoto S; Karlsen TH; Rizell M; Ericzon BG
    Scand J Gastroenterol; 2011 Mar; 46(3):370-5. PubMed ID: 21073376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver transplantation for cholangiocarcinoma.
    Rosen CB; Heimbach JK; Gores GJ
    Transpl Int; 2010 Jul; 23(7):692-7. PubMed ID: 20497401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Kim KH; Lee SG; Park EH; Hwang S; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    Ann Surg Oncol; 2009 Mar; 16(3):623-9. PubMed ID: 19130133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Liver transplantation with a living donor: the first 3 cases in Rotterdam].
    Kazemier G; Metselaar HJ; de Man RA; Tran TC; Groenland TH; Tilanus HW
    Ned Tijdschr Geneeskd; 2008 Apr; 152(14):817-21. PubMed ID: 18491825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience.
    Ghali P; Marotta PJ; Yoshida EM; Bain VG; Marleau D; Peltekian K; Metrakos P; Deschênes M
    Liver Transpl; 2005 Nov; 11(11):1412-6. PubMed ID: 16237695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
    Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
    Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of liver transplantation for hilar cholangiocarcinoma.
    Pandey D; Lee KH; Tan KC
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):248-53. PubMed ID: 17548246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living-donor liver transplantation for Caroli's disease with intrahepatic adenocarcinoma.
    Takatsuki M; Uemoto S; Inomata Y; Egawa H; Kiuchi T; Hayashi M; Ueda M; Tanaka K
    J Hepatobiliary Pancreat Surg; 2001; 8(3):284-6. PubMed ID: 11455493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience.
    Sotiropoulos GC; Kaiser GM; Lang H; Molmenti EP; Beckebaum S; Fouzas I; Sgourakis G; Radtke A; Bockhorn M; Nadalin S; Treckmann J; Niebel W; Baba HA; Broelsch CE; Paul A
    Transplant Proc; 2008 Nov; 40(9):3194-5. PubMed ID: 19010231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer.
    Yoshimi F; Asato Y; Amemiya R; Shioyama Y; Itabashi M
    Hepatogastroenterology; 2001; 48(40):994-8. PubMed ID: 11490856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection and treatment of cholangiocarcinoma.
    Gores GJ
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S30-4. PubMed ID: 11084082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of primary sclerosing cholangitis.
    Björnsson E
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):163-72. PubMed ID: 19305376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ; Wedemeyer J; Kubicka S; Strassburg CP; Manns MP
    J Hepatol; 2008; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Two cases of lower bile duct recurrence resected by pancreatoduodenectomy after hepatectomy for hilar cholangiocarcinoma].
    Nakahira S; Takeda Y; Kawashima H; Mukai Y; Hamanaka M; Uchiyama C; Kanemura T; Okishiro M; Takeno A; Suzuki R; Nakata K; Egawa C; Miki H; Kato T; Nakatsuka S; Tamura S
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2119-21. PubMed ID: 23267996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.